Arnold & Itkin
Recent News About Arnold & Itkin View More
-
Judge accused of high-fiving jurors after $8B Risperdal verdict refuses to step down from trial
PHILADELPHIA – A Philadelphia judge has struck down an attempt to recuse him from future proceedings surrounding a staggering $8 billion punitive damages verdict at the end of a recent trial surrounding anti-psychotic drug Risperdal. -
Attorney: $8 billion Risperdal verdict is 'another black eye' to Philadelphia's reputation
PHILADELPHIA – Johnson & Johnson and its subsidiary Janssen Pharmaceuticals have called a Philadelphia jury’s gigantic verdict of $8 billion in punitive damages against it for alleged malice connected to the marketing of anti-psychotic drug Risperdal “grossly disproportionate” and “a violation of due process” and are seeking to immediately overturn it. -
Breaking: In first test, Philadelphia jury punishes J&J with $8 billion verdict; Thousands more cases remain
PHILADELPHIA – In an unprecedented conclusion to the first-ever punitive damages trial tied to Risperdal, a 12-person jury found Johnson & Johnson and its subsidiary Janssen Pharmaceuticals liable for allegedly knowing and consciously disregarding the potential of the drug to cause gynecomastia to patients like plaintiff Nicholas Murray, and rendered a staggering verdict of $8 billion. -
J&J wants to use plaintiff's own doctors to fight against punitive damages in Risperdal case
PHILADELPHIA – In pre-trial bench memorandums filed over the weekend, Johnson & Johnson believes the testimony of prescribing physicians would provide additional context for its actions in trying to repel a punitive damages claim made against it by a man who alleges he was disfigured by Risperdal’s side effect of gynecomastia.